[Alpha-2 adrenergic receptors and Parkinson's disease].
Bonnet
Anne-Marie
AM
Fédération de Neurologie, Hôpital de La Pitié-Salpetrière, 47-83 Boulevard de l'Hôpital, 75013 Paris, France.
D058669:Adrenergic alpha-2 Receptor Antagonists; D000978:Antiparkinson Agents / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D007980:Levodopa / Q000494:pharmacology / Q000502:physiology / Q000627:therapeutic use; D018696:Neuroprotective Agents / Q000494:pharmacology / Q000627:therapeutic use; D009638:Norepinephrine / Q000172:deficiency; D010300:Parkinson Disease / Q000188:drug therapy* / Q000503:physiopathology*; D010891:Piribedil / Q000494:pharmacology / Q000627:therapeutic use; D018341:Receptors, Adrenergic, alpha-2 / Q000187:drug effects* / Q000502:physiology
D058669:Adrenergic alpha-2 Receptor Antagonists; D000978:Antiparkinson Agents; D018696:Neuroprotective Agents; D018341:Receptors, Adrenergic, alpha-2; D007980:Levodopa; D010891:Piribedil; D009638:Norepinephrine